Previous 10 | Next 10 |
2024-05-27 02:33:11 ET More on Scinai Immunotherapeutics Seeking Alpha’s Quant Rating on Scinai Immunotherapeutics Financial information for Scinai Immunotherapeutics Read the full article on Seeking Alpha For further details see: Scinai Immunother...
Scinai Immunotherapeutics Announces Receipt of a Nasdaq Staff Determination Letter Regarding Shareholders' Equity listing requirements and Hearing to Present a Plan for Regaining Compliance PR Newswire JERUSALEM , May 24, 2024 /PRNewswire/ -- Scinai Immunothera...
Autoimmune illnesses such as multiple sclerosis, rheumatoid arthritis, Crohn’s disease, lupus, scleroderma and psoriasis, usually cause an individual’s immune system to attack normal cells. Recent research has observed annual increases in overall incidence and prevalence of autoi...
Inpixon (INPXV) is expected to report for Q1 2024 Siebert Financial Corp. (SIEB) is expected to report for Q1 2024 Greenwave Technology Solutions Inc. (GWAV) is expected to report for Q1 2024 Bank Hapoalim B.M. ADR (BKHYY) is expected to report for Q1 2024 Gelesis Holdings, Inc. (...
2024-05-16 11:33:51 ET More on Scinai Immunotherapeutics Seeking Alpha’s Quant Rating on Scinai Immunotherapeutics Historical earnings data for Scinai Immunotherapeutics Financial information for Scinai Immunotherapeutics Read the full article on See...
Scinai Immunotherapeutics (NASDAQ: SCNI) , a biopharmaceutical company focused on the development of inflammation and immunology (“I&I”) biological products and on providing contract development and manufacturing organization (“CDMO”) services through i...
Scinai Publishes FY 2023 Financial Statements, Files Annual Report on Form 20-F and Provides Business Update PR Newswire JERUSALEM , May 15, 2024 /PRNewswire/ -- Scinai Immunotherapeutics Ltd. (Nasdaq: SCNI) ("Scinai", or the "Company"), a biopharmaceutical c...
Scinai Immunotherapeutics (NASDAQ: SCNI) is a biopharmaceutical company focused on developing inflammation and immunology (“I&I”) biological products and providing CDMO services through its Scinai Bioservices business unit. The company today announced that it has received a sta...
Scinai Immunotherapeutics Announces Receipt of Nasdaq Delisting Notification and Appeal PR Newswire The Board has Approved a Ratio Change of the ADSs to Non-traded Ordinary Shares (equivalent to a reverse split) Designed to Regain Compliance JERUSALEM , May 6, 20...
Vitamin D plays different roles and is easily available through the sun, meat and plants. Despite this, many individuals are vitamin D deficient. Different studies have looked into the use of vitamin D for the prevention and treatment of different cancers, including bowel, breast, skin and pro...
News, Short Squeeze, Breakout and More Instantly...
Scanner Technologies Corp Company Name:
SCNI Stock Symbol:
OTCMKTS Market:
Scanner Technologies Corp Website:
A look at the top 10 most actives in the United States Conduit Pharmaceuticals Inc. (CDT) rose 40.0% to $0.3361 on volume of 63,970,490 shares Yoshitsu Co. Ltd (TKLF) rose 64.0% to $0.5024 on volume of 62,618,792 shares Silo Pharma Inc. (SILO) rose 91.8% to $2.0522 on volume of 59,055,593...
A look at the top 10 most actives in the United States NVIDIA Corporation (NVDA) fell 0.6% to $128.44 on volume of 203,267,889 shares Faraday Future Intelligent Electric Inc. (FFIE) rose 22.1% to $0.5152 on volume of 200,531,827 shares PROSHARES TRUST (SQQQ) fell 0.7% to $7.46 on volume o...
2024-07-15 12:31:08 ET Scinai Immunotherapeutics Ltd (NASDAQ: SCNI) unveiled promising preclinical outcomes for its innovative anti IL-17A/F antibody fragment (NanoAb) aimed at treating mild to moderate plaque psoriasis. The biotechnology firm’s shares experienced a significa...